Evidence map›Paper›PMID 24029558›Full record

ArticlePreventive medicine2013

Association between documented family history of cancer and screening for breast and colorectal cancer.

Patricia A Carney, Jean P O'Malley, Andrea Gough, David I Buckley, James Wallace, Lyle J Fagnan, Cynthia Morris, Motomi Mori, John D Heintzman, David Lieberman

Abstract read
In one paragraph

Article in Preventive medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.Journal of cancer education : the official journal of the American Association for Cancer Education · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Patterns of colorectal cancer screening uptake in newly eligible men and women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patricia A CarneyDepartment of Family Medicine, Oregon Health & Science University, Portland, OR, USA; Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR, USA. Electronic address: carneyp@ohsu.edu.
Jean P O'Malley
Andrea Gough
David I Buckley
James Wallace
Lyle J Fagnan
Cynthia Morris
Motomi Mori
John D Heintzman
David Lieberman

Funding

OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
NCI NIH HHS P30 CA069533NCI NIH HHS P30CA069533NCRR NIH HHS UL1 RR024140NCRR NIH HHS UL1-RR024140
6 · The paper itself

Abstract

backgroundPrevious research on ascertainment of cancer family history and cancer screening has been conducted in urban settings. PURPOSE: To examine whether documented family history of breast or colorectal cancer is associated with breast or colorectal cancer screening.

methodsMedical record reviews were conducted on 3433 patients aged 55 and older from four primary care practices in two rural Oregon communities. Data collected included patient demographic and risk information, including any documentation of family history of breast or colorectal cancer, and receipt of screening for these cancers.

resultsA positive breast cancer family history was associated with an increased likelihood of being up-to-date for mammography screening (OR 2.09, 95% CI 1.45-3.00 relative to a recorded negative history). A positive family history for colorectal cancer was associated with an increased likelihood of being up-to-date with colorectal cancer screening according to U.S. Preventive Services Task Force low risk guidelines for males (OR 2.89, 95% CI 1.15-7.29) and females (OR 2.47, 95% CI 1.32-4.64) relative to a recorded negative family history. The absence of any recorded family cancer history was associated with a decreased likelihood of being up-to-date for mammography screening (OR 0.70, 95% CI 0.56-0.88 relative to recorded negative history) or for colorectal cancer screening (OR 0.75, 95% CI 0.60-0.96 in females, OR 0.68, 95% CI 0.53-0.88 in males relative to recorded negative history).

conclusionFurther research is needed to determine if establishing routines to document family history of cancer would improve appropriate use of cancer screening.

Indexed as

AgedBreast NeoplasmsColorectal NeoplasmsEarly Detection of CancerFemaleGenetic Predisposition to DiseaseGuideline AdherenceHumansLikelihood FunctionsMaleMiddle AgedOregonPatient Acceptance of Health CareRisk FactorsUtilization ReviewCancer riskCancer screeningEarly detection of cancer

Identifiers

PMID24029558
PMCPMC4041693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.